Market Snapshot: Ventilators & Pulmonary Function Assessment Products Market Sees Moderate Growth
Executive Summary
The global market for ventilators and pulmonary function assessment products is expected to reach $1.7bn by 2022, driven in large part by rising incidences of pulmonary diseases in the elderly population. The larger market segment of diagnostics spirometry products will grow at a faster rate than the smaller pulmonary function testing and disposable products market, driven by an emphasis of disease prevention via early diagnosis in outpatient and alternate care settings. Check out our infographic on the market.
You may also be interested in...
Market Brief: New Triple-Combination Therapies Help Boost Lackluster Inhalation Devices Market
The inhalation devices market will reach $12bn by 2023, driven by the rising prevalence of asthma and COPD worldwide. GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim dominate worldwide sales of inhalation products for asthma and COPD, and are facing generic competition. Generics developers and major pharma players are trying to set themselves apart with better drug-delivery devices.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.